Long COVID Patients Urged to Enroll in U of M Clinical Trial

Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory

A substantial proportion of patients suffer from Post-COVID Syndrome (PCS) with fatigue and impairment of memory and concentration being the most important symptoms. We here set out to perform in-depth neuropsychological assessment of PCS patients referred to the Neurologic PCS clinic compared to patients without sequelae after COVID-19 (non-PCS) and healthy controls (HC) to decipher the most prevalent cognitive deficits. We included n = 60 PCS …

Long COVID patients urged to enroll in U of M clinical trial

The University of Minnesota is one of a few colleges participating in the nationwide study "Reverse LC," to see if the FDA-approved drug Baricitinib, which has been used to treat COVID-19, can also help improve neurocognitive symptoms for people who have Long COVID.

Long COVID patients are desperate for treatments. These trials may help.

By Richard Sima The Washington Post Five years since the pandemic began, millions of people are still grappling with long COVID, even as new patients are joining their ranks. “Considering how far along we are and how tens of millions of people are suffering, we’ve done very little,” said Eric Topol, a professor of translational medicine and the executive vice president of Scripps Research. But researchers are pressing ahead with new clinical tri…

TheVoiceOfJoyce Join the Theater of War/WNYC on a discussion of the effects of Long COVID.

Forwarded this email? Subscribe here for more Be part of the solution and know you’re not alone. Approximately 10% of people infected with Covid 19, have Long Covid. Join our studio audience on May 28, in person or on Zoom! Long COVID Showed Me the Bottom of American Health Care, featuring: Gary Farmer, Irma-Estel Laguerre, Tanis Parenteau, and Lou Diamond Phillips.  MAY 27READ IN APP Register to attend in person or on Zoom Please join us for th…

New research on long-COVID offers hope for patients living with condition

A new clinical study from Cardiff Metropolitan University – in collaboration with Cwm Taf Morgannwg University Health Board (CTM UHB) – has highlighted new biomedical insights into long-COVID and could take existing studies one step closer to finding treatment for patients living with the condition. Long COVID is a new condition which can affect people who have previously had the COVID-19 virus. Symptoms can include heart disease, muscle and joi…

Newly Initiated ADDRESS-LC Trial to Test Bezisterim as Treatment for Neurological Symptoms of Long COVID

BioVie initiates a phase 2 trial for bezisterim, targeting neurological symptoms of Long COVID, aiming to improve patient quality of life.